OVERVIEW

Podcast: Practice-Changing Advances in the Management of Hemophilia is organized by i3 Health and will be held from Jun 21, 2024 - Jun 20, 2025.

STATEMENT OF NEED
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemophilia B, caused by low levels of clotting factor IX. The standard treatment for hemophilia involves replacing the missing blood clotting factor by infusing commercially prepared factor concentrates. However, approximately 15% to 20% of patients will develop an inhibitor, an antibody that prevents the clotting factor from working, resulting in increased complications and the need for more complex management (CDC, 2023). It is vital that clinicians remain up-to-date on the latest data on novel and emerging therapies for hemophilia A and B in order to provide the most tailored treatment options to their patients. In this i3 Health Podcast episode, Dr. Guy Young, Director of the Hemostasis and Thrombosis Program and Professor of Pediatrics at Keck School of Medicine of the University of Southern California (USC), and Dr. Jennifer Davila, Co-Director of the Hemophilia Treatment Center at Montefiore and Associate Professor of Pediatrics at The Children’s Hospital at Montefiore, will explore practice-changing advances in the management of hemophilia.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to

  • Appraise the mechanisms of action, efficacy, safety, and indications of novel and emerging therapies for hemophilia A and B 
  • Evaluate strategies to tailor treatment to individual patients with hemophilia 
  • Assess approaches to address the problem of nonadherence to hemophilia treatment

In this Video Viewpoint Strategy Session, Dr. Guy Young, Director of the Hemostasis and Thrombosis Program and Professor of Pediatrics at Keck School of Medicine of the University of Southern California (USC), and Dr. Jennifer Davila, Co-Director of the Hemophilia Treatment Center at Montefiore and Associate Professor of Pediatrics at The Children’s Hospital at Montefiore, will explore practice-changing advances in the management of hemophilia. 

Credits

JOINTLY ACCREDITED PROVIDER
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS
i3 Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.

Physician Assistants/Associates
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 6/20/2025. PAs should only claim credit commensurate with the extent of their participation. 

Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Nursing Continuing Professional Development
A maximum of 0.75 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.5 ANCC contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 0.75 ANCC contact hours. 

ONCC RECERTIFICATION
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

ONCC review is only for designating content to be used for recertification points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program.

OCN®, CPHON®, CBCN®, AOCNP®, AOCNS®, and BMTCN® renewal candidates may apply 0.75 ILNA points toward:

  • Care Continuum (OCN®, CBCN®, CPHON®, AOCNP®)
  • Care of the Pediatric Hematology and Oncology Patient (CPHON®)
  • Oncology Nursing Practice (OCN®)
  • Professional Practice/Performance (BMTCN®, AOCNP®)
  • Psychosocial Dimensions of Care (AOCNP®, CPHON®, OCN®, CBCN®)
  • Roles of the APRN (AOCNP®)
  • Treatment (OCN®, CBCN®, AOCNP®, CPHON®)

Please note that some of the course content applies to multiple content areas. The numerical value above indicates the maximum amount of points that can be claimed in each domain. The total amount of ILNA points claimed may not exceed the total amount of NCPD awarded from this course.

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 MOC
  • 0.75 Contact Hour
  • 0.75 CPE
  • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantOncologistsFamily PhysiciansHealthcare ProfessionalsPediatriciansHematologistNurse AssistantsFamily PractitionersNurse PractitionersHealth Care PractitionersGeneral Pediatricians

    SPECIALITIES

    HematologyHematology NurseHematology Blood and Marrow TransplantOncologyPediatrics

    RELATED ONLINE COURSES